TMCI — TREACE MED CONCEPTS INC COM

Ownership history in US BANCORP \DE\  ·  10 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in TREACE MED CONCEPTS INC COM (TMCI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 657 +244 +59.1% 0.00% $4K $6.71
2025 Q2 REDUCED 413 -185 -30.9% 0.00% $2K $5.88
2025 Q1 ADDED 598 +20 +3.5% 0.00% $5K $8.39
2024 Q4 ADDED 578 +269 +87.1% 0.00% $4K $7.44
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TMCI price (monthly, adj. close)

Other funds also holding TMCI

As of 2025 Q4 — sorted by position size

Gagnon Advisors, LLC 3Y 7Y 2.39% GAGNON SECURITIES LLC 3Y 7Y 1.55% Birchview Capital, LP 3Y 7Y 0.33% KOTLER KEVIN 0.27% ARMISTICE CAPITAL, LLC 3Y 7Y 0.19% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% Parkman Healthcare Partners LLC 3Y 0.05% Aristides Capital LLC 3Y 0.03% PFM Health Sciences, LP 3Y 7Y 0.01% PARADIGM CAPITAL MANAGEMENT INC/NY 3Y 7Y 0.01%
← Back to US BANCORP \DE\ Holdings